|
|
Curetis AGProfile date: 2024-12-31 Curetis AG is a German medical technology company focused on the development, production, and commercialization of molecular diagnostic solutions. Their primary focus is on the rapid detection of infectious diseases, primarily through their proprietary Cartridge-Based Nucleic Acid Amplification Test (NAT) technology. This technology is designed for use at the point of care (POC), enabling faster diagnosis and treatment initiation compared to traditional laboratory-based methods. Their flagship product, the Unyvero platform, is a fully automated system that utilizes disposable cartridges containing all the necessary reagents for various infectious disease tests. This system is intended for use in hospitals, clinics, and other healthcare settings. The platform aims to provide results within hours, allowing for quicker implementation of appropriate therapies and potentially improved patient outcomes. The tests offered through the Unyvero platform cover a range of pathogens, including those causing respiratory tract infections, gastrointestinal infections, and urinary tract infections. Continue… |
|